Candel Therapeutics shares owned by Barclays
Quarter-by-quarter ownership of Candel Therapeutics (CADL) shares owned by Barclays
from 13F filings
Historical chart of Barclays investment in Candel Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Candel Therapeutics held by Barclays consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Candel Therapeutics by Barclays
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-12-31 | $392k | 69k | 5.65 |
| 2025-09-30 | $304k | 60k | 5.10 |
| 2025-06-30 | $346k | 68k | 5.06 |
| 2025-03-31 | $177k | 31k | 5.66 |
| 2024-12-31 | $297k | 34k | 8.65 |
| 2024-09-30 | $199k | 29k | 6.94 |
| 2024-06-30 | $42k | 6.7k | 6.25 |